Loading…
Adenoviral gene transfer in a rat fracture model
For the enhancement of fracture healing, either purified proteins or vectors for expression of growth factors in situ may be used. Adenoviral vectors directly convert cells to express a transgene. However, the cell types which are preferentially infected and the time of expression during fracture he...
Saved in:
Published in: | Laboratory animals (London) 2002-10, Vol.36 (4), p.455-461 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c412t-98748f6e22f4d0740d4469d7328d0517bfe4e9f255902948a0d42a5edf1f8b153 |
---|---|
cites | |
container_end_page | 461 |
container_issue | 4 |
container_start_page | 455 |
container_title | Laboratory animals (London) |
container_volume | 36 |
creator | van Griensven, M Lobenhoffer, P Barke, A Tschernig, T Lindenmaier, W Krettek, C Gerich, T G |
description | For the enhancement of fracture healing, either purified proteins or vectors for
expression of growth factors in situ may be used. Adenoviral vectors
directly convert cells to express a transgene. However, the cell types which are
preferentially infected and the time of expression during fracture healing are
currently not known. The adenoviral type 5 vectors used in this study are replication
incompetent viruses, one encoding β-galactosidase (β-GAL) and one green fluorescent
protein. Femora of 35 Sprague-Dawley rats were fractured. Three days after
stabilization with Kirschner wire, 1012 pfu viral suspension were injected
into the fracture zone. As a control, five animals received injections of adenovirus
type 2. Animals were sacrificed after 3 days, 1, 2 and 4 weeks. Fractures healed
radiographically within 2-3 weeks. All specimens were examined for β-GAL and green
fluorescent protein (GFP) expression. Fibroblast and osteoblasts within callus tissue
displayed a high transgene expression (week 1). A decrease of expression was observed
during the observation period. In this experimental study, we have demonstrated that
all cells of the primary callus can be transfected using adenoviral vectors, which
provide a tool to further investigate adenoviral transfer of growth factors such as
bone morphogenetic protein-2 (BMP-2). |
doi_str_mv | 10.1258/002367702320389134 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72614361</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1258_002367702320389134</sage_id><sourcerecordid>72614361</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-98748f6e22f4d0740d4469d7328d0517bfe4e9f255902948a0d42a5edf1f8b153</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotlb_gAfZk7e1mdnsJjmW4hcUvOh5yW4mZct-1GRX8N-b0oIHwcsMA8_7wjyM3QJ_AMzVknPMCinjRJ4pDZk4Y3OQuUoBQJ6z-QFII4EzdhXCLp4gFL9kM8BMF6j5nPGVpX74arxpky31lIze9MGRT5o-MYk3Y-K8qcfJU9INltprduFMG-jmtBfs4-nxff2Sbt6eX9erTVoLwDHVSgrlCkJ0wnIpuBWi0FZmqCzPQVaOBGmHea45aqFMBNDkZB04VUGeLdj9sXfvh8-Jwlh2TaipbU1PwxRKiQWIrIAI4hGs_RCCJ1fufdMZ_10CLw-eyr-eYuju1D5VHdnfyElMBJZHIJgtlbth8n389r_KH6Jpbak</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72614361</pqid></control><display><type>article</type><title>Adenoviral gene transfer in a rat fracture model</title><source>SAGE</source><creator>van Griensven, M ; Lobenhoffer, P ; Barke, A ; Tschernig, T ; Lindenmaier, W ; Krettek, C ; Gerich, T G</creator><creatorcontrib>van Griensven, M ; Lobenhoffer, P ; Barke, A ; Tschernig, T ; Lindenmaier, W ; Krettek, C ; Gerich, T G</creatorcontrib><description>For the enhancement of fracture healing, either purified proteins or vectors for
expression of growth factors in situ may be used. Adenoviral vectors
directly convert cells to express a transgene. However, the cell types which are
preferentially infected and the time of expression during fracture healing are
currently not known. The adenoviral type 5 vectors used in this study are replication
incompetent viruses, one encoding β-galactosidase (β-GAL) and one green fluorescent
protein. Femora of 35 Sprague-Dawley rats were fractured. Three days after
stabilization with Kirschner wire, 1012 pfu viral suspension were injected
into the fracture zone. As a control, five animals received injections of adenovirus
type 2. Animals were sacrificed after 3 days, 1, 2 and 4 weeks. Fractures healed
radiographically within 2-3 weeks. All specimens were examined for β-GAL and green
fluorescent protein (GFP) expression. Fibroblast and osteoblasts within callus tissue
displayed a high transgene expression (week 1). A decrease of expression was observed
during the observation period. In this experimental study, we have demonstrated that
all cells of the primary callus can be transfected using adenoviral vectors, which
provide a tool to further investigate adenoviral transfer of growth factors such as
bone morphogenetic protein-2 (BMP-2).</description><identifier>ISSN: 0023-6772</identifier><identifier>EISSN: 1758-1117</identifier><identifier>DOI: 10.1258/002367702320389134</identifier><identifier>PMID: 12396290</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Adenoviridae - genetics ; Animals ; beta-Galactosidase - genetics ; beta-Galactosidase - metabolism ; Disease Models, Animal ; Femoral Fractures - diagnostic imaging ; Femoral Fractures - genetics ; Fibroblasts - metabolism ; Fracture Healing - genetics ; Genetic Therapy - methods ; Genetic Vectors ; Green Fluorescent Proteins ; Luminescent Proteins - genetics ; Luminescent Proteins - metabolism ; Male ; Osteoblasts - metabolism ; Radiography ; Rats ; Rats, Sprague-Dawley ; Transfection - methods</subject><ispartof>Laboratory animals (London), 2002-10, Vol.36 (4), p.455-461</ispartof><rights>Laboratory Animals Ltd. 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-98748f6e22f4d0740d4469d7328d0517bfe4e9f255902948a0d42a5edf1f8b153</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79364</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12396290$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Griensven, M</creatorcontrib><creatorcontrib>Lobenhoffer, P</creatorcontrib><creatorcontrib>Barke, A</creatorcontrib><creatorcontrib>Tschernig, T</creatorcontrib><creatorcontrib>Lindenmaier, W</creatorcontrib><creatorcontrib>Krettek, C</creatorcontrib><creatorcontrib>Gerich, T G</creatorcontrib><title>Adenoviral gene transfer in a rat fracture model</title><title>Laboratory animals (London)</title><addtitle>Lab Anim</addtitle><description>For the enhancement of fracture healing, either purified proteins or vectors for
expression of growth factors in situ may be used. Adenoviral vectors
directly convert cells to express a transgene. However, the cell types which are
preferentially infected and the time of expression during fracture healing are
currently not known. The adenoviral type 5 vectors used in this study are replication
incompetent viruses, one encoding β-galactosidase (β-GAL) and one green fluorescent
protein. Femora of 35 Sprague-Dawley rats were fractured. Three days after
stabilization with Kirschner wire, 1012 pfu viral suspension were injected
into the fracture zone. As a control, five animals received injections of adenovirus
type 2. Animals were sacrificed after 3 days, 1, 2 and 4 weeks. Fractures healed
radiographically within 2-3 weeks. All specimens were examined for β-GAL and green
fluorescent protein (GFP) expression. Fibroblast and osteoblasts within callus tissue
displayed a high transgene expression (week 1). A decrease of expression was observed
during the observation period. In this experimental study, we have demonstrated that
all cells of the primary callus can be transfected using adenoviral vectors, which
provide a tool to further investigate adenoviral transfer of growth factors such as
bone morphogenetic protein-2 (BMP-2).</description><subject>Adenoviridae - genetics</subject><subject>Animals</subject><subject>beta-Galactosidase - genetics</subject><subject>beta-Galactosidase - metabolism</subject><subject>Disease Models, Animal</subject><subject>Femoral Fractures - diagnostic imaging</subject><subject>Femoral Fractures - genetics</subject><subject>Fibroblasts - metabolism</subject><subject>Fracture Healing - genetics</subject><subject>Genetic Therapy - methods</subject><subject>Genetic Vectors</subject><subject>Green Fluorescent Proteins</subject><subject>Luminescent Proteins - genetics</subject><subject>Luminescent Proteins - metabolism</subject><subject>Male</subject><subject>Osteoblasts - metabolism</subject><subject>Radiography</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Transfection - methods</subject><issn>0023-6772</issn><issn>1758-1117</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LAzEQhoMotlb_gAfZk7e1mdnsJjmW4hcUvOh5yW4mZct-1GRX8N-b0oIHwcsMA8_7wjyM3QJ_AMzVknPMCinjRJ4pDZk4Y3OQuUoBQJ6z-QFII4EzdhXCLp4gFL9kM8BMF6j5nPGVpX74arxpky31lIze9MGRT5o-MYk3Y-K8qcfJU9INltprduFMG-jmtBfs4-nxff2Sbt6eX9erTVoLwDHVSgrlCkJ0wnIpuBWi0FZmqCzPQVaOBGmHea45aqFMBNDkZB04VUGeLdj9sXfvh8-Jwlh2TaipbU1PwxRKiQWIrIAI4hGs_RCCJ1fufdMZ_10CLw-eyr-eYuju1D5VHdnfyElMBJZHIJgtlbth8n389r_KH6Jpbak</recordid><startdate>20021001</startdate><enddate>20021001</enddate><creator>van Griensven, M</creator><creator>Lobenhoffer, P</creator><creator>Barke, A</creator><creator>Tschernig, T</creator><creator>Lindenmaier, W</creator><creator>Krettek, C</creator><creator>Gerich, T G</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20021001</creationdate><title>Adenoviral gene transfer in a rat fracture model</title><author>van Griensven, M ; Lobenhoffer, P ; Barke, A ; Tschernig, T ; Lindenmaier, W ; Krettek, C ; Gerich, T G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-98748f6e22f4d0740d4469d7328d0517bfe4e9f255902948a0d42a5edf1f8b153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adenoviridae - genetics</topic><topic>Animals</topic><topic>beta-Galactosidase - genetics</topic><topic>beta-Galactosidase - metabolism</topic><topic>Disease Models, Animal</topic><topic>Femoral Fractures - diagnostic imaging</topic><topic>Femoral Fractures - genetics</topic><topic>Fibroblasts - metabolism</topic><topic>Fracture Healing - genetics</topic><topic>Genetic Therapy - methods</topic><topic>Genetic Vectors</topic><topic>Green Fluorescent Proteins</topic><topic>Luminescent Proteins - genetics</topic><topic>Luminescent Proteins - metabolism</topic><topic>Male</topic><topic>Osteoblasts - metabolism</topic><topic>Radiography</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Transfection - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Griensven, M</creatorcontrib><creatorcontrib>Lobenhoffer, P</creatorcontrib><creatorcontrib>Barke, A</creatorcontrib><creatorcontrib>Tschernig, T</creatorcontrib><creatorcontrib>Lindenmaier, W</creatorcontrib><creatorcontrib>Krettek, C</creatorcontrib><creatorcontrib>Gerich, T G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Laboratory animals (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Griensven, M</au><au>Lobenhoffer, P</au><au>Barke, A</au><au>Tschernig, T</au><au>Lindenmaier, W</au><au>Krettek, C</au><au>Gerich, T G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adenoviral gene transfer in a rat fracture model</atitle><jtitle>Laboratory animals (London)</jtitle><addtitle>Lab Anim</addtitle><date>2002-10-01</date><risdate>2002</risdate><volume>36</volume><issue>4</issue><spage>455</spage><epage>461</epage><pages>455-461</pages><issn>0023-6772</issn><eissn>1758-1117</eissn><abstract>For the enhancement of fracture healing, either purified proteins or vectors for
expression of growth factors in situ may be used. Adenoviral vectors
directly convert cells to express a transgene. However, the cell types which are
preferentially infected and the time of expression during fracture healing are
currently not known. The adenoviral type 5 vectors used in this study are replication
incompetent viruses, one encoding β-galactosidase (β-GAL) and one green fluorescent
protein. Femora of 35 Sprague-Dawley rats were fractured. Three days after
stabilization with Kirschner wire, 1012 pfu viral suspension were injected
into the fracture zone. As a control, five animals received injections of adenovirus
type 2. Animals were sacrificed after 3 days, 1, 2 and 4 weeks. Fractures healed
radiographically within 2-3 weeks. All specimens were examined for β-GAL and green
fluorescent protein (GFP) expression. Fibroblast and osteoblasts within callus tissue
displayed a high transgene expression (week 1). A decrease of expression was observed
during the observation period. In this experimental study, we have demonstrated that
all cells of the primary callus can be transfected using adenoviral vectors, which
provide a tool to further investigate adenoviral transfer of growth factors such as
bone morphogenetic protein-2 (BMP-2).</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>12396290</pmid><doi>10.1258/002367702320389134</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0023-6772 |
ispartof | Laboratory animals (London), 2002-10, Vol.36 (4), p.455-461 |
issn | 0023-6772 1758-1117 |
language | eng |
recordid | cdi_proquest_miscellaneous_72614361 |
source | SAGE |
subjects | Adenoviridae - genetics Animals beta-Galactosidase - genetics beta-Galactosidase - metabolism Disease Models, Animal Femoral Fractures - diagnostic imaging Femoral Fractures - genetics Fibroblasts - metabolism Fracture Healing - genetics Genetic Therapy - methods Genetic Vectors Green Fluorescent Proteins Luminescent Proteins - genetics Luminescent Proteins - metabolism Male Osteoblasts - metabolism Radiography Rats Rats, Sprague-Dawley Transfection - methods |
title | Adenoviral gene transfer in a rat fracture model |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T10%3A26%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adenoviral%20gene%20transfer%20in%20a%20rat%20fracture%20model&rft.jtitle=Laboratory%20animals%20(London)&rft.au=van%20Griensven,%20M&rft.date=2002-10-01&rft.volume=36&rft.issue=4&rft.spage=455&rft.epage=461&rft.pages=455-461&rft.issn=0023-6772&rft.eissn=1758-1117&rft_id=info:doi/10.1258/002367702320389134&rft_dat=%3Cproquest_cross%3E72614361%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c412t-98748f6e22f4d0740d4469d7328d0517bfe4e9f255902948a0d42a5edf1f8b153%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=72614361&rft_id=info:pmid/12396290&rft_sage_id=10.1258_002367702320389134&rfr_iscdi=true |